Loading chat...

IN SB0403

Bill

Official Source

Status

Introduced

1/10/2017

Primary Sponsor

James Merritt

Click for details

Origin

Senate

2017 Regular Session

AI Summary

  • Defines "blister pack" as preformed plastic packaging used for pharmaceuticals, effective July 1, 2017.
  • Requires all schedule II controlled substances distributed or dispensed under written, electronic, or oral prescriptions to be packaged in a blister pack.
  • Maintains existing exemption for dosages medically required for not more than 48 hours dispensed by or directed by a practitioner or medication dispensed directly by a practitioner other than a pharmacy.
  • Prohibits refilling of schedule II substance prescriptions.
  • Amends IC 35-48 to establish the blister pack requirement for schedule II drug distribution and dispensing.

Legislative Description

Sale of schedule II drugs. Requires a prescribed schedule II controlled substance to be distributed or dispensed in a blister pack.

Last Action

First reading: referred to Committee on Health and Provider Services

1/10/2017

Committee Referrals

Health and Provider Services1/10/2017

Full Bill Text

No bill text available